BIOVIE INC (BIVI) Stock Analyst Earnings Estimates
NASDAQ:BIVI - Nasdaq - US09074F4054 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | N/A 239.73% | N/A 149.38% | N/A 92.07% | |||||||||||
| EBITDA YoY % growth | N/A | N/A | -380K | -1.32M -247.37% | -2.14M -62.12% | -2.27M -6.07% | -2.46M -8.37% | -137.82M -5,502.44% | -27.02M 80.39% | -44.85M -65.99% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -320K | -230K 28.13% | -430K -86.96% | -1.55M -260.47% | -2.37M -52.90% | -2.5M -5.49% | -2.69M -7.60% | -138.05M -5,031.97% | -27.25M 80.26% | -45.08M -65.43% | N/A -0.76% | N/A 23.13% | N/A 36.65% | N/A 148.73% | N/A 679.21% | N/A 108.62% | N/A 78.23% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A 84.35% | -15.60 -36.10% | N/A 22.85% | N/A 62.63% | N/A 86.39% | N/A 821.67% | N/A 192.38% | N/A 106.24% | N/A 44.66% |
All data in USD
| Q3 / 25 | Q4 / 25 | |
|---|---|---|
| EPS Q2Q % growth | -0.17 48.33% | -0.14 6.67% |
| Revenue Q2Q % growth | ||
| EBITDA Q2Q % growth | N/A | N/A |
| EBIT Q2Q % growth | -9.638M -24.57% | -10.071M -110.25% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.46 79.09% | -0.16 | -0.30 | -181.86% |
| Q1 2025 Q2Q % growth | 94.37% | -0.16 | % | |
| Q4 2024 Q2Q % growth | 93.88% | -0.15 | % | |
| Q3 2024 Q2Q % growth | 92.20% | -0.34 | % | |
| Q2 2024 Q2Q % growth | -2.20 56.00% | -3.23 | 1.03 | 31.96% |
| Q1 2024 Q2Q % growth | -2.90 23.68% | -3.16 | 0.26 | 8.29% |
| Q4 2023 Q2Q % growth | -2.50 24.24% | -4.07 | 1.57 | 38.57% |
| Q3 2023 Q2Q % growth | -4.30 -53.57% | -3.62 | -0.68 | -18.75% |
| Q2 2023 Q2Q % growth | -5.00 -78.57% | -2.58 | -2.42 | -94.14% |
| Q1 2023 Q2Q % growth | -3.80 | -2.91 | -0.89 | -30.72% |
| Q4 2022 Q2Q % growth | -3.30 96.76% | -3.80 | 0.50 | 13.15% |
| Q3 2022 Q2Q % growth | -2.80 | -4.32 | 1.52 | 35.15% |
| Q2 2022 Q2Q % growth | -2.80 | -3.16 | 0.36 | 11.45% |
| Q4 2021 Q2Q % growth | -101.80 -37,603.70% | -23.66 | -78.14 | -330.19% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 0% | 0% |
| Revenue | N/A | N/A | N/A | N/A |